ISSN: 0340-7004
Journal Home
Journal Guideline
Cancer Immunology, Immunotherapy Q1 Unclaimed
Cancer Immunology, Immunotherapy is a journal indexed in SJR in Medicine (miscellaneous) and Immunology with an H index of 121. It has a price of 3190 €. It has an SJR impact factor of 1.723 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.723.
Cancer Immunology, Immunotherapy focuses its scope in these topics and keywords: cells, cell, t, cancer, immune, human, cd, responses, tumor, suppressor, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -


3190 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1.723
SJR Impact factor121
H Index360
Total Docs (Last Year)579
Total Docs (3 years)14754
Total Refs3970
Total Cites (3 years)556
Citable Docs (3 years)6.93
Cites/Doc (2 years)40.98
Ref/DocOther journals with similar parameters
Journal of Clinical Oncology Q1
Annals of Oncology Q1
Annual Review of Public Health Q1
The Lancet Global Health Q1
Nature Reviews Disease Primers Q1
Compare this journals
Aims and Scope
Best articles by citations
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-a2a and interleukin-2
View moreThe human repertoire of antibody specificities against Thomsen-Friedenreich and Tn-carcinoma-associated antigens as defined by human monoclonal antibodies
View morePostoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine
View moreImmunological inhibition of carcinogenesis
View moreStructure and function of ETAA16: a novel cell surface antigen in Ewing's tumours
View moreTherapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancer
View moreModulation of costimulation to enhance tumor immunity
View moreEffect of ibuprofen on monocyte activation by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (CGP 19835A): Can ibuprofen reduce fever and chills without compromising immune stimulation?
View moreThe effect of ranitidine on cellular immunity in patients with multiple myeloma
View moreThe augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2
View moreGeneration of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells
View moreSelective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis
View moreThe use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines
View moreProduction of a human monoclonal antibody recognising a determinant on mouse IgG2b from a patient receiving mouse monoclonal antibody for diagnostic imaging
View moreEffect of picibanil (OK432) on neutrophil-mediated antitumor activity: Implication of monocyte-derived neutrophil-activating factors
View moreGraft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation a
View moreAdenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro
View moreSusceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-a-treated chronic myelogenous leukaemia patients
View moreEffects of lipopolysaccharide on interleukin-2-induced cytotoxic activity of murine splenocyte cultures: role of prostaglandin E2 and interferons
View moreCommon variable immunodeficiency and malignancy: a report of two cases and possible explanation for the association
View moreTwo-dimensional gel analysis of polypeptides from normal, preneoplastic and neoplastic mouse mammary tissues
View moreThe effects of ?GalCer-induced TCRV?24'V?11+ natural killer T cells on NK cell cytotoxicity in umbilical cord blood
View moreInhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide
View moreTumour escape: antitumour effectors too much of a good thing?
View more
Comments